Suppr超能文献

接受造血细胞移植的青少年和青年的心理复原力与痛苦:压力管理中促进心理复原力的随机试验

Resilience and distress among adolescents and young adults receiving hematopoietic cell transplantation: The Promoting Resilience in Stress Management randomized trial.

作者信息

Rosenberg Abby R, Taylor Mallory R, Fladeboe Kaitlyn M, Zhou Chuan, Levine Deena R, Johnston Emily E, Freyer David R, Comiskey Liam, Junkins Courtney C, Bradford Miranda, Odom J Nicholas, Baker K Scott, Yi-Frazier Joyce P

机构信息

Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.

出版信息

Cancer. 2024 Oct 15;130(20):3519-3529. doi: 10.1002/cncr.35440. Epub 2024 Jun 21.

Abstract

BACKGROUND

Adolescents and young adults (AYAs) receiving hematopoietic cell transplantation (HCT) are at high risk of poor psychosocial health. This study aimed to determine whether the Promoting Resilience in Stress Management (PRISM) intervention mitigated these risks during the first 6 months posttransplant.

METHODS

This multisite, parallel, randomized trial was conducted from April 2019 to March 2023. Eligible AYAs were aged 12-24 years, English speaking, and within 1 month of HCT for cancer or cancer predisposition syndrome. They were assigned 1:1 to PRISM (a brief, skills-based intervention targeting "resilience resources" [stress management, goal setting, cognitive reframing, and meaning making]) or usual care (UC). Outcomes included total symptoms of depression and anxiety (Hospital Anxiety and Depression Scale; primary outcome), hope (Snyder Hope Scale), resilience (10-item Connor-Davidson Resilience Scale), and health-related quality of life (HRQOL; Pediatric Quality of Life Inventory Cancer Module). Analyses leveraged multivariable linear regressions; exploratory analyses assessed the influence of baseline depression or anxiety.

RESULTS

Of 94 enrolled and randomized AYAs, the mean age was 16.7 years (SD, 4.2); 43 (46%) were female, 56 (60%) were non-Hispanic White, 22 (23%) were Hispanic, and nine (10%) were Black. Most (77%) had leukemia. Of n = 50 randomized to PRISM and n = 44 to UC, 37 (74%) and 33 (73%) completed all study procedures, respectively. In intention-to-treat analyses, PRISM did not affect 6-month depression and anxiety (β = -1.1; 95% CI, -3.7 to 1.5), hope (β = 0.83; 95% CI, -3.3 to 4.9), resilience (β = -0.01; 95% CI, -3.0 to 3.0), or HRQOL (β = 1.5; 95% CI, -4.7 to 7.9). Among AYAs with preexisting anxiety or depression, PRISM recipients reported greater 6-month improvements in hope (score change, +3.71; SD, 6.9) versus UC recipients (score change, -2.76; SD, 6.5) (p = .04).

CONCLUSIONS

Resilience coaching did not influence outcomes in this sample. Exploratory findings suggest it may be more effective when directed toward those with concurrent distress.

摘要

背景

接受造血细胞移植(HCT)的青少年和青年(AYA)心理社会健康状况不佳的风险很高。本研究旨在确定压力管理中的韧性促进(PRISM)干预措施是否能在移植后的前6个月减轻这些风险。

方法

这项多中心、平行、随机试验于2019年4月至2023年3月进行。符合条件的AYA年龄在12 - 24岁之间,说英语,且在因癌症或癌症易感性综合征接受HCT的1个月内。他们被1:1分配到PRISM组(一种针对“韧性资源”[压力管理、目标设定、认知重构和意义构建]的简短、基于技能的干预措施)或常规护理(UC)组。结果包括抑郁和焦虑的总症状(医院焦虑和抑郁量表;主要结果)、希望(斯奈德希望量表)、韧性(10项康纳 - 戴维森韧性量表)以及健康相关生活质量(HRQOL;儿童生活质量量表癌症模块)。分析采用多变量线性回归;探索性分析评估基线抑郁或焦虑的影响。

结果

在94名登记并随机分组的AYA中,平均年龄为16.7岁(标准差4.2);43名(46%)为女性,56名(60%)为非西班牙裔白人,22名(23%)为西班牙裔,9名(10%)为黑人。大多数(77%)患有白血病。在随机分配到PRISM组的n = 50名和UC组的n = 44名中,分别有37名(74%)和33名(73%)完成了所有研究程序。在意向性分析中,PRISM对6个月时的抑郁和焦虑(β = -1.1;95%置信区间,-3.7至1.5)、希望(β = 0.83;95%置信区间,-3.3至4.9)、韧性(β = -0.01;95%置信区间,-3.0至3.0)或HRQOL(β = 1.5;95%置信区间,-4.7至7.9)没有影响。在已有焦虑或抑郁的AYA中,PRISM组受试者报告的6个月时希望改善程度更大(得分变化,+3.71;标准差6.9),而UC组受试者为(得分变化,-2.76;标准差6.5)(p = 0.04)。

结论

韧性指导对该样本的结果没有影响。探索性研究结果表明,针对同时存在困扰的人群可能更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验